Similar articles

• Hypertonic-hyperoncotic solutions improve cardiac function in children after open-heart surgery.

  Schroth M, Plank C, Meissner U, Eberle KP, Weyand M, Cesnjevar R, Dötsch J, Rascher W. Schroth M, et al. Pediatrics. 2006 Jul;118(1):e76-84. doi: 10.1542/peds.2005-2795. Epub 2006 Jun 2. Pediatrics. 2006. PMID: 16751617 Clinical Trial.
• Hypertonic-hyperoncotic solutions decrease cardiac troponin I concentrations in peripheral blood in a porcine ischemia-reperfusion model.

  Bertsch T, Denz C, Janke C, Weiss M, Fassbender K, Luiz T, Ellinger K, Krieter H. Bertsch T, et al. Exp Toxicol Pathol. 2001 Jun;53(2-3):153-6. doi: 10.1078/0940-2993-00176. Exp Toxicol Pathol. 2001. PMID: 11484833
• Effects of hyperoncotic or hypertonic-hyperoncotic solutions on polymorphonuclear neutrophil count, elastase- and superoxide-anion production: a randomized controlled clinical trial in patients undergoing elective coronary artery bypass grafting.

  Molter GP, Silomon M, Bauer C, Ziegeler S, Soltesz S. Molter GP, et al. Acta Anaesthesiol Scand. 2007 Aug;51(7):914-21. doi: 10.1111/j.1399-6576.2007.01341.x. Epub 2007 Jun 18. Acta Anaesthesiol Scand. 2007. PMID: 17578462 Clinical Trial.
• [Hypertonic-hyperoncotic solutions: possibilities and limits].

  Kröll W, Gassmayr SE, Izmail S, List WF. Kröll W, et al. Praxis (Bern 1994). 1998 May 13;87(20):683-9. Praxis (Bern 1994). 1998. PMID: 9633225 Review. German.
• [Hypertonic solutions and intracranial pressure].

  Favre JB, Ravussin P, Chiolero R, Bissonnette B. Favre JB, et al. Schweiz Med Wochenschr. 1996 Sep 28;126(39):1635-43. Schweiz Med Wochenschr. 1996. PMID: 8927967 Review. French.